Home/Filings/4/0001140361-15-035079
4//SEC Filing

Arbutus Biopharma Corp 4

Accession 0001140361-15-035079

$ABUSCIK 0001447028operating

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 4:20 PM ET

Size

6.9 KB

Accession

0001140361-15-035079

Insider Transaction Report

Form 4
Period: 2015-09-11
Murray Mark J.
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2015-09-11219,4280 total
    Exercise: $0.44From: 2008-03-30Exp: 2015-09-12Common shares (219,428 underlying)
  • Exercise/Conversion

    Common Shares

    2015-09-11$0.44/sh+219,428$97,514284,389 total
Footnotes (1)
  • [F1]Expressed in Canadian dollars.

Documents

1 file

Issuer

Arbutus Biopharma Corp

CIK 0001447028

Entity typeoperating
IncorporatedBritish Columbia, Canada

Related Parties

1
  • filerCIK 0001447028

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:20 PM ET
Size
6.9 KB